This study was performed to assess the effect of glucocorticoids (dexamethasone) on insulin-and IGF-I-regulated muscle protein metabolism in adult and old rats. Muscle atrophy occurred more rapidly in old rats, and recovery of muscle mass was impaired when compared with adults. Muscle wasting resulted mainly from increased protein breakdown in adult rat but from depressed protein synthesis in the aged animal. Glucocorticoid treatment significantly decreased the stimulatory effect of insulin and IGF-I on muscle protein synthesis in adult rats by 25·9 and 58·1% respectively. In old rats, this effect was even greater, being 49·3 and 100% respectively. With regard to muscle proteolysis, glucocorticoids blunted the anti-proteolytic action of insulin and IGF-I in both age groups. During the recovery period, adult rats reversed the glucocorticoidinduced resistance of muscle protein metabolism within 3 days, at which time old rats still exhibited the decrease in insulin-regulated proteolysis. In conclusion, the higher sensitivity of old rat muscle to glucocorticoids may in part result from the greater modification of the effects of insulin and IGF-I on muscle protein metabolism. These responses to glucocorticoids in old rats may be associated with the emergence of muscle atrophy with advancing age.
Introduction
During aging, a progressive loss of muscle mass has been described for both humans (Forbes 1976 ) and rodents (Klitgaard et al. 1989 , Holloszy et al. 1991 . This loss of protein results from an imbalance between rates of protein synthesis and degradation. This imbalance is not obvious when basal rates of protein turnover are measured (Dujovne & Azarnoff 1975 , Makrides 1983 , El Haj et al. 1986 , Goldspink et al. 1987 , but can be detected in rats during the postprandial period or endurance training (Mosoni et al. 1995) . We hypothesized that glucocorticoids may be involved in the emergence of muscle atrophy with advancing age. We first reported an increased sensitivity of muscle protein turnover to dexamethasone (DEX) with aging, which may create a slight but continuous imbalance between muscle protein synthesis and breakdown. In addition, we demonstrated that glucocorticoid action on skeletal muscle protein turnover differed markedly between adult and old rats and clearly showed that the recovery of muscle mass after such treatment was impaired in old rats and may result in muscle atrophy, especially when another stress situation is initiated before muscle mass recovery is complete.
Glucocorticoids are known to be potent diabetogenic agents resulting from both hepatic and peripheral resistance to the action of insulin (Amatruda et al. 1985) . It is now well known that the action of insulin on muscle glucose uptake (Weinstein et al. 1995) , glycogen synthesis (Leighton et al. 1987) and proteolysis (Louard et al. 1994) are reduced after glucocorticoid treatment. The mechanisms by which steroids alter insulin action on skeletal muscle remain unclear. Indeed, in skeletal muscle, the first cellular events involved in the action of insulin, i.e increase in insulin receptor number (Block & Buse 1989 , Giorgino et al. 1993 , Saad et al. 1993 , insulin receptor autophosphorylation (Block & Buse 1989 , Saad et al. 1993 ) and tyrosine phosphorylation of insulin receptor substrate-1 (IRS-1) (Giorgino et al. 1993 , Saad et al. 1993 , are not modified by glucocorticoid treatment. Only a decrease in the association/activation of phosphatidylinositol 3-kinase with IRS-1 in response to insulin has been recorded in young rats (Giorgino et al. 1993 , Saad et al. 1993 . Thus glucocorticoid-induced muscle atrophy may result from both the steroid effect per se and modification of insulin action on protein metabolism. On the basis of these observations, we hypothesized that the hypersensitivity of old rats to steroids and their inability to restore their muscle protein mass rapidly may result in part from both greater and longer-lasting glucocorticoid modification of anabolic hormones such as insulin and insulin-like growth factor-I (IGF-I). To substantiate this hypothesis, the effect of DEX on the insulin and IGF-I control of protein turnover in adult and old rats was studied in vitro in epitrochlearis muscles. 
Materials and Methods

Chemicals
Animals
Adult (6-8 months) and old (18 months) male SpragueDawley rats were purchased from Iffa-Credo (L'Arbresle, France) and housed under controlled environmental conditions (temperature 22 C; 12 h dark period starting at 1800 h). They were given free access to commercial laboratory chow and water before the experiments were performed. Both adult and old rats were randomly divided into a control and a DEX-treated group. DEX (a synthetic glucocorticoid analogue that does not bind to plasma binding proteins) was given daily (at 0900 h) via the drinking water. DEX concentration was adjusted every day on the basis of drinking water intake the day before. Adult and old animals received 508 87 and 541 98 µg/kg per day respectively. DEX was given for 5 days in old rats but for 6 days in adults to generate a similar degree of muscle atrophy in the two groups, since muscle wasting was more rapid in aged animals (Dardevet et al. 1995) . Rats were allowed to recover for either 3 (R+3) or 7 (R+7) days. As DEX has been reported to decrease food intake, all groups were pair-fed to the group that had the lowest food intake (i.e DEX-treated old rats). Animals were killed under anesthesia with sodium pentobarbital (6·0 mg/100 g body weight) after an overnight fast. Blood samples were collected for glycemia assessment and for measuring plasma insulin levels. Epitrochlearis muscles were dissected intact for incubation.
Muscle incubation
On the day of the experiment, the skin on the fore limb was removed and the epitrochlearis muscle was excised and rinsed in ice-cold Krebs-Henseleit bicarbonate buffer (NaCl 120 mM, KCl 4·8 mM, NaHCO 3 25 mM, CaCl 2 2·5 mM, KH 2 PO 4 1·2 mM and MgSO 4 1·2 mM, pH 7·4, supplemented with 5 mM HEPES, 0·17 mM leucine, 0·20 mM valine, 0·10 mM isoleucine, 0·1% BSA (99% fatty acid free)). Muscles were then transferred to plastic tubes containing 2 ml buffer saturated with 95% O 2 /5% CO 2 gas mixture and preincubated for 30 min. The effect of insulin and IGF-I was then assessed by incubating the muscles in fresh medium of the same composition supplemented with or without 30 nM hormone for 2 h. Incubation was continued for a further hour in fresh medium containing 0·5 mM -[
14 C]phenylalanine (0·15 µCi/ml). At the end of the incubation, incubation medium was frozen at 20 C until assay, and muscles were blotted and homogenized in 10% trichloroacetic acid (TCA). Samples were centrifuged at 10 000 g for 10 min at 4 C and TCA-insoluble material was washed three times with 10% TCA. The resultant pellet was solubilized in 1 M NaOH at 37 C for determination of protein and radioactivity incorporated into muscle protein. Tissue protein mass was determined using the bicinchoninic acid procedure (BCA; Pierce Chemical Co., Rockford, IL, USA), and protein-bound radioactivity was measured using scintillation counting. Protein synthesis was calculated by dividing the protein-bound radioactivity by the specific radioactivity of the phenylalanine in the incubation medium. It was expressed as nmol phenylalanine incorporated/mg protein per h. Protein degradation was determined as described by Tischler et al. (1982) . Because tyrosine is neither synthesized nor degraded by muscle, the release of this amino acid from muscle into the incubation medium directly reflects net protein breakdown. Proteolysis was then estimated by the sum of net tyrosine release into the incubation medium and protein synthesis after conversion of the rate of phenylalanine incorporation into proteins into tyrosine equivalents (Tischler et al. 1982) . Protein degradation was expressed as nmol tyrosine/mg protein per h.
Statistical analysis
Data are expressed as mean ... or mean ... of the absolute difference between values from pair-fed control and DEX-treated animals of the same age. Statistical evaluation of the data was performed using Student's t-test or a two-way ANOVA for each age, with treatment and stage as the main factors. The effects of these factors were tested at each stage by the Fischer posteriori test of comparison of means, and were considered significant when P<0·05.
Results
Animal characteristics
At the end of the DEX treatment, epitrochlearis muscle atrophy was similar in adult and old rats ( 30·0 11·2 and 26·5 10·2 mg respectively) ( Fig. 1 ). As we have previously shown, old rats are more sensitive to glucocorticoids than adults, as similar muscle atrophy was generated with a shorter treatment period (5 vs 6 days). After 3 days of DEX withdrawal, epitrochlearis mass increased in adult rats but was still significantly lower ( 16·7 8·4 mg) than in control pair-fed animals. In contrast, muscle atrophy continued in the old rats ( 35·2 12·2 mg; P<0·05) ( Fig. 1) . Adult rats had normalized their epitrochlearis mass after 7 days of recovery, whereas old rats still exhibited marked muscle atrophy ( 35·4 14·3 mg; P<0·05) when compared with pair-fed controls (Fig. 1) . At the end of the DEX treatment, both adult and old rats showed a significant increase in blood glucose when compared with their pair-fed controls (3·46 0·44 vs 1·70 0·08 g/l in adult and 4·94 0·35 vs 1·68 0·08 g/ l in old rats; P<0·05). This hyperglycemia was associated with hyperinsulinemia (203 20 vs 35 10 and 235 37 vs 49 7 µU/ml in adult and old rats respectively; P<0·05).
Basal protein synthesis and degradation
DEX-induced muscle atrophy in adult rats resulted from increased proteolysis (+36·5%; P<0·05) without any significant modification of the rate of protein synthesis (Fig. 2) . In contrast, in old rat muscle, loss of muscle mass resulted from depressed protein synthesis ( 25·8%; P<0·05) along with slightly increased proteolysis (+16·9%) (Fig. 2) . After DEX withdrawal, adult muscle proteolysis returned to control values whereas protein synthesis was progressively stimulated (+19·3% and +64·4% vs controls at R+3 and R+7 respectively; P<0·05) (Fig. 2) . Old rats differed from adults in that muscle protein synthesis only returned to control levels and was not stimulated above this level. These observations are in agreement with the delayed recovery of muscle protein mass in old rats compared with adult animals.
Insulin and IGF-I responsiveness of muscle protein turnover in the presence of DEX
As expected, insulin and IGF-I significantly stimulated (P<0·05) muscle protein synthesis in pair-fed control adult rats (0·135 0·005 and 0·126 0·014 vs 0·075 0·004 nmol phenylalanine/mg protein per h respectively; P<0·05 vs basal) (Fig. 3) . When adults were treated with DEX, both hormones were still able to stimulate protein synthesis but to a lesser extent than in pair-fed controls. Indeed, the incremental increase in protein synthesis above basal due to the effect of insulin and IGF-I only represented 74·1 and 41·9% of the corresponding values in the pair-fed control group (P<0·05 vs basal). Note that the impairment in hormone responsiveness after DEX treatment was more pronounced with IGF-I than with insulin (Fig. 3) .
Insulin and IGF-I also stimulated protein synthesis in pair-fed control old rats (P<0·05 vs basal) (Fig. 3) . However, DEX treatment had a greater effect on muscle protein synthesis responsiveness to the hormones than in adults (Fig. 3) . The effect of IGF-I was totally abolished and the effect of insulin, although significant (P<0·05 vs basal), only represented 50·7% of the value of pair-fed controls (reflected by the incremental increase of protein synthesis above basal).
Insulin significantly reduced the rate of proteolysis in epitrochlearis muscles from both adult and old control rats (i.e. 21·2% and 15·3% respectively; P<0·05), but its effect was totally abolished when rats were treated with DEX (Fig. 4) . IGF-I had no significant effect on muscle proteolysis whatever the age group of the rats (Fig. 4) .
Insulin and IGF-I responsiveness of muscle protein turnover after DEX withdrawal
At R+3 and R+7, insulin stimulated protein synthesis in both pair-fed and treated muscles from both age groups, and the maximum response was not significantly different between control and DEX-treated animals at R+3 and R+7 (Fig. 3) , showing that, in muscles from both adult and old rats, normal responsiveness of protein synthesis to insulin was restored within 3 days. When adult and old muscles were incubated in the presence of IGF-I, the maximum response of muscle protein synthesis at R+3 was also similar in pair-fed and treated-rats (Fig. 3) but was higher in DEX-treated than in pair-fed controls at R+7 in both age groups (i.e. +44·4 and +29·4% in adult and old rats respectively; P<0·05).
In the presence of either insulin or IGF-I, rates of muscle proteolysis were not significantly different between controls and treated adults at R+3 and R+7 (Fig. 4) , showing that, in adult rats, normal responsiveness of muscle proteolysis to both hormones was restored within 3 days. In contrast, in old rats, the maximum response of muscle proteolysis recorded in the presence of insulin was still significantly increased in the DEX-treated animals compared with controls (Fig. 4) . When decremental decrease under basal values was considered, old DEXtreated rats still exhibited a significant 21·9% reduction in responsiveness of muscle proteolysis to insulin. The rate of proteolysis regulated by insulin and IGF-I was no longer significantly different between the DEX-treated and control old rats at R+7 (Fig. 4) .
Discussion
As reported previously (Dardevet et al. 1995) , DEX induced skeletal muscle protein wasting in both adult and old rats. A similar degree of atrophy was, however, generated with a shorter treatment period in old rats, suggesting increased sensitivity to glucocorticoids with aging. As muscle atrophy results from an imbalance between protein synthesis and degradation, a better knowledge of the regulation of these pathways is needed to understand this higher sensitivity to glucocorticoids in old rats. We here demonstrate that glucocorticoid treatment mainly increased protein degradation in adult rat muscle but mainly depressed protein synthesis in the aged rat muscle. These observations were made using epitrochlearis muscle incubated in the absence of any hormone. Thus their physiological relevance must be considered with caution since the well-known interactive effect of glucocorticoids and insulin on muscle protein turnover was not taken into account. Indeed, it has previously been shown that glucocorticoids alter the action of insulin on both protein synthesis (Odedra & Millward 1982 , Southorn et al. 1990 ) and proteolysis (Southorn et al. 1990) in muscle from young growing rats. Louard et al. (1994) also showed that DEX treatment antagonizes the anti-proteolytic action of insulin on human skeletal muscle. In contrast with the effects of insulin, the responsiveness of muscle protein metabolism to IGF-I under the influence of glucocorticoids has not been studied very extensively. Hellstern et al. (1996) found, however, that IGF-I failed to reverse the DEX-induced catabolic state in growing piglets, suggesting that protein metabolism became totally resistant to this hormone. Our study extends these findings to adult and old rats.
Our results clearly demonstrate that DEX treatment decreased the ability of insulin and IGF-I to stimulate protein synthesis in both adult and old rat muscles. However, the effect of the glucocorticoid was more pronounced in old than adult rats for both insulin (49·3 and 25·9% decreased responsiveness respectively) and IGF-I (100 and 58·1% decreased responsiveness respectively). The consequence of this hormonal resistance is that the decrease in muscle protein synthesis between control pair-fed and DEX-treated old rats was more enhanced than in adults under insulin ( 37·3%) and IGF-I ( 40·3%) when compared with basal conditions ( 25·8%). With regard to proteolysis, DEX treatment resulted in the abolition of the ability of insulin to inhibit muscle protein degradation in both adult and old rats. Thus, as for protein synthesis, the difference in proteolysis between control pair-fed and DEX-treated rats was higher in the presence of insulin (+52·9 and +31·7% in adult and old rats respectively) or IGF-I (+51·4 and +28·1% in adult and old rats respectively) than in their absence (+36·5 and +16·9% in adult and old rats respectively). In conclusion, our results demonstrate that glucocorticoids may induce muscle protein wasting per se, but the effect may also be the result of the decreased in vivo anabolic effect of both insulin and IGF-I in old and adult rats. Compared with that in adults, the higher Figure 4 Effect of DEX (DX) and subsequent recovery on the responsiveness of muscle protein degradation to insulin and IGF-I in adult and old rats. Epitrochlearis muscles from adult and old rats were excised and incubated in vitro as described in Materials and Methods. Rates of proteolysis were measured as described in Fig. 2 . Values shown are means S.E.M. for 4-12 muscles in each group. *P<0·05 vs basal values from the same group; †P<0·05 vs the value recorded in the pair-fed group (PF).
resistance of old rat muscles to both hormones could also explain their higher sensitivity to DEX in generating muscle protein wasting. This was not so clearly demonstrated when basal muscle protein turnover only was considered.
Glucocorticoids are known to be potent diabetogenic agents associated with marked hyperinsulinemia. Since DEX-induced insulin resistance was less pronounced in adult than old rats, it might be hypothesized that the DEX-induced increase in plasma insulin levels may reverse more efficiently the effect of glucocorticoids on muscle protein synthesis in adult than in old rats. However, such a phenomenon cannot explain the in vivo hypersensitivity of old rats to glucocorticoids. Indeed, it has been shown that increased basal insulin levels failed to stimulate in vivo muscle protein synthesis in both adult and old rats (Mosoni et al. 1993) , demonstrating that insulin at physiological levels already maximally stimulates muscle protein synthesis. Thus the hyperinsulinemia generated by DEX cannot counteract the effects of DEX on muscle protein synthesis, and the difference in insulin-stimulated protein synthesis that we observed in vitro should also be found in vivo. The effect of insulin on glucocorticoidinduced muscle protein wasting has also been studied in young growing rats. The results of the experiment of Southorn et al. (1990) agree with ours; they demonstrated that the responsiveness of muscle protein synthesis to insulin was altered when animals were treated with glucocorticoids and that insulin infusion in vivo did not counteract the decrease in muscle protein synthesis generated by corticosterone. In contrast, the study of Tomas et al. (1984) showed that, in diabetic rats treated with corticosterone, insulin replacement in vivo produced improved muscle protein synthesis in a dose-related fashion, suggesting that insulin was able to counteract the effect of the steroids. However, it is important to note that, in these experiments when induced insulinemia reached control values and above, insulin did not have any further beneficial effect on muscle protein synthesis, and the rate of muscle protein synthesis of diabetic rats treated with corticosterone and insulin remained low when compared with control rats. In other words, insulin was only able to counteract the effects of glucocorticoids on muscle protein synthesis in the range of physiological hypoinsulinemia. In contrast with their effect on insulin, glucocorticoids have been shown to depress plasma IGF-I levels (Tomas et al. 1992 , Hellstern et al. 1996 . Thus the DEX-induced IGF-I resistance could not be counteracted in vivo by a compensatory increase in IGF-I. Furthermore, the decrease in blood IGF-I in DEX-treated rats may generate in vivo lower protein metabolism responses than those we recorded in vitro with concentrations allowing maximum response. In this case, the glucocorticoid-induced IGF-I resistance would be greater in vivo than in vitro. Taken together, these findings indicate that the consequences of the DEX-induced IGF-I resistance of muscle protein metabolism could be more damaging in vivo than the defective insulin action.
The mechanisms by which glucocorticoids induce insulin and IGF-I resistance of skeletal muscle remain unclear. Studies investigating the first cellular events involved in insulin action showed that glucocorticoids decreased the association/activation of phosphatidylinositol 3-kinase with IRS-1 in response to insulin in young rat skeletal muscle (Giorgino et al. 1993 , Saad et al. 1993 , suggesting that glucocorticoids may induce muscle insulin resistance by altering this intracellular signalling pathway. On the other hand, Petrides et al. (1994) demonstrated that 24 h of mild hyperinsulinemia abolished the whole body anti-proteolytic action of insulin in humans. Thus we cannot exclude the possibility that, in our experiment, DEX may have also altered indirectly the insulin effect on muscle proteolysis by reaching its physiological level.
After DEX withdrawal, adult rats rapidly restored their muscle protein mass within 7 days, whereas old animals still showed a significant reduction of epitrochlearis mass. The recovery of muscle mass after this treatment was thus impaired in old rats. The basal protein metabolism study showed that, when compared with pair-fed controls, DEX-treated adults normalized their rates of protein synthesis and proteolysis within 3 days and had even increased the rate of protein synthesis at day 7, whereas old rats did not show any increase in the rate of muscle protein synthesis. Thus adult rats showed a positive nitrogen balance within 7 days, whereas old rats only equilibrated it during this time period. These differences between old and adult rats in basal muscle protein turnover during the recovery period should be enhanced in the presence of hormones. Indeed (1) insulin-regulated proteolysis was still affected in old rats after 3 days of DEX withdrawal and (2) the hyper-responsiveness of protein synthesis to IGF-I in DEX-treated muscles was more marked in adult than in old rats 7 days after DEX withdrawal, allowing them to restore their muscle protein mass more efficiently in the presence of IGF-I. Taken together, these findings are consistent with a higher rate of muscle mass recovery in adult rats.
In conclusion, our study brings new insights into the effect of glucocorticoids on muscle atrophy and protein turnover in adult and old rats. The overall effect of glucocorticoid treatment resulted from both glucocorticoid action per se and insulin and IGF-I resistance of muscle protein turnover. Old rats were more sensitive to the treatment than adults. This was mainly due to the dramatic decrease in protein synthesis caused by the treatment in old animals particularly under hormonal regulation (proteolysis being affected whatever the age). Moreover, the recovery of muscle mass after glucocorticoid withdrawal was slow in old rats compared with adults. Accordingly, proteolysis remained at a high rate and resistant to the inhibitory effect of insulin in old rats. In contrast, protein synthesis increased and specifically showed a hyper-responsiveness to IGF-I in adult rats. These responses to glucocorticoids in old rats may help to explain the emergence of muscle atrophy with advancing age.
